Thyroid

Papers
(The H4-Index of Thyroid is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Radiofrequency Ablation of Low-Risk Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Including Patients with More than 10 Years of Follow-up358
The Epidemiology of Thyroid Eye Disease in Olmsted County, Minnesota, 2005–2020250
Incidental Thyroid Nodules on Computed Tomography: A Systematic Review and Meta-Analysis Examining Prevalence, Follow-Up, and Risk of Malignancy182
Role of Thyrotropin-Releasing Hormone in Regulating Fibroblast Growth Factor 21 in Mouse Pancreatic β Cells132
Development and Progression of Thyroid Disease in PTEN Hamartoma Tumor Syndrome: Refined Surveillance Recommendations102
A Multicenter, Single-Blind, Case-Control, Immunohistochemical Study of Orbital Tissue in Thyroid Eye Disease101
Future Meetings86
A Conversation with Samuel Refetoff, MD: How Treating One Family Stimulated a Lifelong Series of Major Discoveries in Thyroid Physiology and Disease78
35th Anniversary of Thyroid—Journal of the American Thyroid Association77
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Thyroid76
Regular Call Oral Abstracts75
International Women’s Day: An Occasion for a Tribute to Women Leaders in the American Thyroid Association73
Minimally Invasive Ablative Treatments for Benign Thyroid Nodules: Current Evidence and Future Directions72
Re: “Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status” by Yamamoto et al.68
Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction60
Letter to the Editor: ETV6-NTRK2 Fusion Identified in a Patient with Medullary Thyroid Carcinoma60
Stage-Dependent Death Hazard and Conditional Survival of Patients with Papillary Thyroid Cancer58
Investigating Levothyroxine Use and Its Association with Thyroid Health in Patients with Hypothyroidism: A Community Pharmacy Study54
A Cross-Sectional Survey of Patient Treatment Choice in a Multicenter Prospective Cohort Study on Active Surveillance of Papillary Thyroid Microcarcinoma (MAeSTro)50
A Novel Levothyroxine Solution Results in Similar Bioavailability Whether Taken 30 or Just 15 Minutes Before a High-Fat High-Calorie Meal50
The Scientific Contributions of Martin Surks, MD, MACP: A Pioneer in Thyroid Hormone Physiology, Subclinical Hypothyroidism, and Endocrine Education47
Molecular and Clinical Features of Congenital Hypothyroidism Due to Multiple DUOX2 Variants45
Discoveries Around the Hypothalamic–Pituitary–Thyroid Axis41
A Comprehensive Review of Thyroid Hormone Metabolism in the Gut and Its Clinical Implications41
A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion40
Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers40
Medullary Thyroid Cancer with Ectopic Cushing's Syndrome: A Case Report and Systematic Review of Detailed Cases from the Literature39
Lymphocytic Thyroiditis Transcriptomic Profiles Support the Role of Checkpoint Pathways and B Cells in Pathogenesis39
Preliminary Evidence of Potential Association Between Exposure to Estriol-Containing Skincare Cosmetics Sold in China and Autoimmune Thyroid Disease38
Correction to: The Diagnostic Value of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differe38
Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma36
The American Thyroid Association 1923–2023: Honoring Our Past, Embracing Our Future36
Improved Diagnostic Accuracy of Thyroid Fine-Needle Aspiration Cytology with Artificial Intelligence Technology35
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Rece34
Abstract Author Index34
0.3027229309082